IBI-Ag is focused on discovering and developing new types of biological solutions for insect control that utilize environmentally friendly technology.

The Product & Advantages

IBI-Ag products offer a cost-effective, potent alternative to products currently on the market. The breakthrough technology presents a new mode of action, making it an effective alternative to technologies that focus solely on the insect’s nervous system and are unsafe for human consumption.

  • Suitable for fermentation to enable low-cost production
  • Highly effective, with a lower resistance rate than traditional methods
  • Stable in varied conditions, a significant advantage
  • Naturally derived, a green technology

The Founding Team

  • Rony Oren Benaroya, PhD, co-founder & CTO: 10+ years’ R&D experience in biotech start-ups, including leading R&D in two incubator companies involved in virology and synthetic biology; postdoctorate, Weizmann Institute of Science; PhD, agriculture, The Hebrew University of Jerusalem
  • Professor Amir Ayali, co-founder & adviser: 25+ years’ experience in insect physiology, neurobiology, and behavior research; recently funded projects include Ministry of Agriculture’s Center of Excellence for developing novel approaches to fight locusts; professor, School of Zoology, Tel Aviv University

Trendlines’ director: Nitza Kardish


Founded: April 2017; incubated July 2018
Stage: Technology development
The Trendlines Group, Bayer Trendlines Ag Innovation Fund
Achievements: Optimization of the target agent; completed first plant, greenhouse study

Background & Market

A market for bioinsecticides is growing rapidly each year due to their low toxic impact on humans, animals, the environment, and increased legislation against traditional pesticides. With insects causing billions of dollars annually, the agricultural market is still largely dependent on synthetic pesticides for crop protection, despite their toxicity and reduced efficacy because of increased insect resistance. Broad crop distribution continues to spread the insect pest problem globally, producing a dire need for novel and effective organic formulations.

As chemical insecticides become less effective and are subject to increasingly stringent regulations, growers are more willing to try biological options because they cost less and offer a greener, more effective option. Today, biopesticides make up only 5% of the total crop protection market, approximately $3 billion in value worldwide (Olson et al., 2013).

The bioinsecticides sector is projected to reach $4.5 billion by 2023, at a CAGR of 8.6%, to comprise more than 7% of the total crop protection market (Lux Research, Inc.). IBI-Ag is positioned at the forefront of developing new technologies in the biopesticides market as its novel solutions help solve the global insect epidemic.

tractor spraying crops in a field
Controlling insects using novel biological technology


Rony Oren Benaroya, PhD, CTO

IBI-Ag portfolio card

Font Resize